Botanical species · safety record

Bryonia alba

The EFSA Compendium of Botanicals holds 4 constituent measurements for Bryonia alba. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Bryonia alba L.

4Constituent measurements

0Safety records

2Cited sources

150Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 150 licensed products naming Bryonia alba as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

Fresh root harvested before shoots are produced
Fresh root harvested before the plant comes into flower
Racine
Root
Roots collected before flowering
Tincture of the root

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Cucurbitacin b	Roots and other underground parts	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier
Cucurbitacin i	Roots and other underground parts	Solvent extraction	≤ 0.125 Percent	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier
Cucurbitacin i	Roots and other underground parts	Solvent extraction	≥ 0.0348 Percent	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier
Cucurbitacins	Unspecified	Solvent extraction	—	—	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Toker, G., Erdemoglu, N., Toker, M.C. High performance liquid chromatographic analysis of cucurbitacins in some Bryonia species. Fabad journal of pharmaceutical sciences, 2000, vol. 25, no. 4, p. 153-156.
Konopa, J., Zielinsky, J., Matuszkiewicz, A. Cucurbitacins, cytotoxic and antitumor substances from Bryonia alba. I. Isolation and identification. Arzneimittel-forschung, 1974, p. 1554-1557.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature